REPORT (d) transgenic pig facilities; (e) biomaterials and encapsulation; and (f) immunosuppression and tolerance induction. The guidance document from the Second Global Consultation (Geneva, 2011) was also included in these discussions.
No takes yet. Share an insight, caveat, or question.
Hawthorne et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: